CACD Archive Login Register My Manuscripts Contact
Instructions for Authors

1. Aims and Scope

A. Aims and Scope

Clinical Archives of Communication Disorders (CACD) publishes peer-reviewed research and other scholarly articles on normal and abnormal processes. The journal is an international channel for both basic research on communication processes and clinical research pertaining to the screening, diagnosis, and management of communication disorders; as well as their etiologies and characteristics. CACD seeks to not only advance evidence-based practice by disseminating the results of new studies but also to provide a forum for critical reviews and meta-analyses of previously published work.

B. Open Access Policy

Clin Arch Commun Disord is a free open access journal. Every article published from CACD is distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium; provided the original work is properly cited.

C. Publication Ethics

CACD will follow the guidelines of the Committee on Publication Ethics (COPE, http://publicationethics.org/).

(1) Originality and Previous Publication

All submitted manuscripts should be original and not under consideration for publication simultaneously by other scientific journals. No part of an accepted manuscript should be published in any other scientific journal without the permission of the editorial board. If duplication is discovered, manuscripts may be rejected and the concerned authors’ names and institutes will be informed in the journal. The authors will also incur penalties.

(2) Authorship

Authorship should be credited to those who have had direct involvement in the study and who fulfill the following criteria: (a) made significant contributions to either the conception or design of, or data collection, analyses and/or interpretation for, the work; AND (b) drafted the work or undertook critical revisions for important intellectual content; AND (c) approved the final version for publication. The primary investigator is designated as the first author of the study, unless contested by the other authors.
The corresponding author is directly responsible for communication about and revision of the submitted manuscript. In the case of a change in authorship, a written explanation must be submitted; changes to either the first or corresponding author(s) require approval by the editorial board.

(3) Conflicts of Interest

The corresponding author of an article should inform the editor of any potential conflicts of interest that may influence the authors’ interpretation of the data. Such conflicts must be disclosed during the online submission process and could include financial support from or private connections with commercial organizations, political pressure from interest groups, or academic problems. The editor will decide whether this information should be included in the published paper, and will consult the corresponding author before publication. In particular, all funding sources for research should be explicitly disclosed.

(4) Research Ethics or Ethical Considerations

If the research involves human participants, the manuscript should explicitly discuss informed consent and approval from an institutional review board.

2. Guidelines for Authors

A. Categories of Manuscripts

Manuscripts include original articles, review articles, case reports, and letters to the editor.

(1) Original Articles

These articles present important new research results from basic and clinical investigations in the areas of communication sciences and disorders.
Note: Strictly theoretical papers should also include a detailed review of the relevant literature and be submitted as Review Articles.

(2) Review Articles

These articles present a comprehensive overview of previous research or theory in an area of communication sciences and disorders. Commissioned by the editorial board from an expert in that field, articles are aimed at a knowledgeable, but not necessarily expert, audience in that area.

(3) Case Reports

These articles can be submitted for publication when one of the following criteria is met: (a) reporting a rare case or condition; (b) observing atypical symptoms and/or signs; (c) introducing new diagnostic or therapeutic methods; or (d) finding atypical clinical and/or laboratory results for populations. Descriptions of single or multiple clinical cases should be unique, deal with cases of exceptional interest or innovation, and, preferably, be a first-time report.

(4) Letters to the Editor

Critical or advisory comments, which add new and important insights on the topic, may be submitted for providing alternative interpretations or views about articles previously published in CACD. Letters being considered for publication will usually be referred to the author(s) of the original article for their response; and if appropriate, both will be published in the same issue. Letters will be published at the discretion of the editor and can be subject to abridgement and editing for style and content.

B. Format of Manuscripts

Manuscripts should be submitted in English. The manuscript should use an 11-point font size and be double spaced on 21.0 cm x 29.7 cm (A4) paper in MS Word (doc or docx) format. Authors should submit the following in separate files: (1) cover letter, (2) title page, (3) manuscripts, (4) tables, and (5) figures (Letters to the Editor should not contain tables, figures, or supplementary data). The manuscript file should contain an abstract, main body, references, and figure legends. All pages of the manuscript file should be numbered consecutively, starting with the abstract. Authors should type, where possible, all mathematical and chemical symbols, equations, and formulas, and identify all unusual symbols the first time they are used. References should be in Vancouver style, as described below.

(1) Cover Letter

The cover letter must include the name, telephone and fax numbers, and postal and email addresses of the person to whom correspondence and proofs are to be sent.

(2) Title Page

Title page with article title, authors’ full name(s) and affiliation(s), corresponding author’s e-mail, running title (less than 50 characters), and acknowledgments, if any. If the research was presented at a conference or meeting, the name, location, and date of the conference or meeting should be given.

(3) Manuscripts
  1) Abstract

Only Original Articles, Review Articles, and Case Reports should incorporate an abstract, which must be included twice: (i) separately, where indicated, at http://www.e-cacd.org; and (ii) as part of the whole manuscript.

  • Original Articles: Factual and comprehensive abstracts of 250 words maximum should be presented in a structured format—Objectives, Methods, Results, and Discussion & Conclusions. The abstract should not contain references. Authors should avoid the use of abbreviations and acronyms, and general statements such as "the significance of the results is discussed." Abstracts should be accompanied by a maximum of 5 keywords.
  • Review Articles: Factual and comprehensive abstracts of 250 words maximum should be presented in a paragraph without headings. The abstract should not contain references. Authors should avoid the use of abbreviations and acronyms, as well as general statements such as "the significance of the results is discussed." Abstracts should be accompanied by a maximum of 5 keywords.
  • Case Reports: Structured abstracts of 150 words maximum should be supplied, accompanied by a maximum of 3 keywords.
  • Letters to the Editor: These should not contain an abstract.

  2) Main Body

Main Body of approximately 7,000 words should be presented in a structured format.

  • Original Articles: Manuscripts should be divided into sections in the following order:

Introduction: This should give readers a comprehensive introduction to the topic discussed, including references to related literature. Authors should state the aims and objective of the study, along with specific research questions to be addressed, if appropriate, and also explain how the study contributes to existing knowledge by citing relevant literature.

Methods: Authors should clearly describe the sample, including all important demographic and clinical characteristics, and explain how the sample size is appropriate for the purpose(s) of the research. They should describe the research methods in sufficient detail so that the research can be duplicated by other interested researchers. This section should contain an affirmation that authors have adhered to relevant ethical guidelines, especially for studies involving humans and animals.

Results: Authors should avoid reporting the same data in tables/figures and the main text. The study findings should be presented clearly and logically.

Discussion & Conclusions: Authors should begin this section with a brief summary of the main results, followed by a discussion of their theoretical or practical importance. Authors should restrict themselves to findings reported in the Results section, and not introduce new data in this section. They should also note the limitations of the study and scope for further research.

  • Review Articles: The main body should be structured in the following order: Introduction, Main Text, Conclusion.
  • Case Reports: Following the Abstract, the manuscript should be structured in the following order: an Introduction of a least one paragraph, briefly describing the background and significance of the case; Case Report; a Discussion, focusing on the uniqueness of the case, but not containing an extensive review of the disorder, and documenting and explaining the clinical findings concisely.
  • Letters to the Editor: They should be limited to approximately 500 words of text, with no more than 5 references, one of which should be to the relevant CACD article. They should have a maximum of 3 authors.

  3) References

References should follow the Vancouver style:

  • All citations in the text must have a corresponding entry in the reference list and vice versa.
  • Identify references within the text using consecutive Arabic numerals in brackets (e.g., [1], [2-4], and [5,7,9]. Citation numbers in the text should be placed before punctuation marks.
  • Entries in the reference list should be listed in order of mention in the text.
    Where there are up to 6 authors, list all names; where there are more than 6 authors, list the first 6 followed by “et al.”

  4) Figure legends

Figure legends should be provided after the references.

(4) Tables   

Tables should not be mixed with the text. They should be provided in a separate file.

(5) Figure   

Figures should not be mixed with the text. They should be provided in a separate file. Only JPG/JPEG, PNG, PPT, TIF/TIFF, EPS formats are acceptable.

C. Accepted Manuscripts

(1) Copyright

The Korean Association of Speech-Language Pathologists (KSLP) is the copyright owner of all papers published in CACD, and thus holds the right to publish, reproduce, distribute, and print the contents in other types of media. Authors of accepted papers must complete the Copyright Transfer and Author Consent Forms, both of which can be downloaded from the CACD online submission page (http://submit.e-cacd.org/). It is the authors’ responsibility to request permission from the original publisher for any material (text, illustrations, and tables) contained within their paper that is being reproduced, and a letter of permission must be supplied to CACD.
The Submission Application and Copyright Transfer Forms must contain the title of the manuscript, date of submission, name of corresponding author(s), affiliation(s), and handwritten signature(s).

(2) Proofs

All manuscripts are subject to copyediting, and the corresponding author will be emailed page proofs to check the accuracy of typesetting. Authors may be charged for any alterations other than those to correct typesetting errors.
Although CACD will endeavor to publish articles promptly and accurately, proofreading is the sole responsibility of the authors, who will remain accountable for all statements made in their article. Please note that publication may proceed if no response is received.

D. Peer Review of Manuscripts

The editorial board retains the right to request minor stylistic amendments and major alterations that might influence the scientific content of the paper. The journal follows a double-blinded peer review. Submitted manuscripts will be reviewed by three peer reviewers, selected from the editorial board’s panel of experts. If deemed necessary, an additional statistical review may be performed. Following peer review, the editorial board will decide whether the manuscript will be

(1) accepted for publication
(2) subject to minor revision
(3) subject to major revision or
(4) rejected for publication.

For manuscripts subject to either minor or major revision, the corresponding author must resubmit the revised manuscript online, along with a point-by-point response to each reviewer’s comments and detailed explanation of the changes made. If necessary, the editorial board may change the structure and phrasing of the manuscript without compromising the integrity of the original paper. The editorial board will email the corresponding author of their decision, and those manuscripts requiring correction will be withheld from publication in the interim. If a manuscript is not resubmitted within 2 months of notification, it will be assumed that the authors have withdrawn their submission. Accepted manuscripts will be published online at http://www.e-cacd.org following final approval by the editor-in-chief. In general, accepted manuscripts will be published in order of submission, depending on the category and date of acceptance.

E. Review and Publication Charges

CACD, which is fully supported by the Korean association of Speech Language Pathologists (K-SLP) has no reviewing, or any publication charges.

Copyright© The Korean Association of Speech-Language Pathologists. All rights reserved.
Editorial Office
#409, 102 SK-Hub BULD, 461 Samil-daero, Jongno-gu, Seoul 03147, Korea
Tel: +82-10-7542-5282   Fax: +82-2-795-2726   E-mail: editor@e-cacd.org      Privacy Policy      Powered by M2community